Gateway 2011: Labconco Corporation
Your online Gateway to Labconco Corporation in 2011
8811 Prospect Avenue
Kansas City, MO 64132
800-821-5525/816-333-8811
Fax: 816-363-0130
www.labconco.com
Labconco has been manufacturing laboratory equipment since 1925. We sell through a worldwide network of laboratory supply distributors. Our laboratory equipment is marketed to pharmaceutical, industrial, life science, environmental, clinical and crime laboratories. The wide variety of products include biological safety cabinets, fume hoods, glove boxes, glassware washers, freeze dry systems, carbon-filtered enclosures, balance enclosures, bulk powder enclosures, laboratory animal research enclosures, evaporation systems and centrifugal concentrators. Three of Labconco’s major product lines contribute toward LEED credits: fume hoods, biosafety cabinets, and glassware washers. Labconco is ISO 9001 certified and is a member of the USGBC.
Protector® Filtered Glove Boxes provide inlet and outlet HEPA or ULPA filtration and a leak-tight physical barrier to protect the operator from exposure to potentially hazardous materials.
The FreeZone® -105°C 4.5 Liter Benchtop Freeze Dry Systems have ice holding capacity for light to moderate loads and have dual refrigeration systems for samples with very low eutectic points.
FreeZone® -105°C 4.5 Liter Benchtop Freeze Dry Systems
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
